BRUSSELS (Reuters) - The European Commission will detail on Friday a mechanism to require both notification and authorisation of COVID-19 vaccine exports from the bloc, after drugmakers cut scheduled deliveries of doses to the EU's 27 countries.
The EU, which has ordered vaccines collectively, learnt last week that AstraZeneca would reduce deliveries of its vaccine, set to be approved this week, by around 60% due to production problems. There have also been shortfalls in supplies of the Pfizer-BioNTech vaccine.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!